Since 1995, Martin Dow Limited has paved the strategic roadmap to expand and lead the framework for Martin Dow
Group. Under Martin Dow Limited, we employ 1600+ employees countrywide and market over 90+ brands.
We manufacture market research-based products and world-class branded generics at our two cGMP compliant manufacturing facilities based in Karachi and Lahore.
Martin Dow Marker began its journey in 2016 after Merck Pakistan divested its share to the Martin Dow Group. Under this entity, we employ 2000+ employees and market over 60+ brands.
We manufacture high-quality and world-renowned brands for our communities at its two cGMP compliant facilities in Karachi and Quetta.
Martin Dow Specialities (Pvt.) Ltd. (MDSPL) is one of Pakistan’s leading life science businesses, acquired by Martin Dow Group in 2016. It has two core business areas, i.e., Medical Diagnostics and Chemicals.
As one of the leading suppliers, MDSPL offers and integrates diagnostic solutions that address the challenges of today’s in-vitro diagnostics solutions, covering clinical chemistry, hematology, electrolytes, reagents, and immunoassays. We also aim to help customers in research solutions understand biological function and disease through our portfolio of different products and services.
Martin Dow Pharmaceuticals is a CMO (Contract Manufacturing Organization) based in France. We operate under EU cGMP compliant and ANSM certified facility. We produce drugs as per the highest quality of EMA (European Medical Agency) standards for our partners based in Europe and beyond.
Martin Dow Healthcare is a full-service CDMO (Contract Development and Manufacturing Organization) in France, serving the nutraceutical industry across Europe and beyond. We develop innovative Nutraceutical solutions under our certified manufacturing facility. Our certifications reflects our commitment to the highest quality standards.